| Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle? S Liabeuf, M Pepin, CFM Franssen, D Viggiano, S Carriazo, ... Nephrology Dialysis Transplantation (Oxford University Press) 37 …, 2022 | 64 | 2022 |
| Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment M Pépin, AC Ferreira, M Arici, M Bachman, M Barbieri, IA Bumblyte, ... Nephrology Dialysis Transplantation 37 (Supplement_2), ii23-ii32, 2022 | 61 | 2022 |
| Profiling of cardiac β-adrenoceptor subtypes in the cardiac left ventricle of rats with metabolic syndrome: Comparison with streptozotocin-induced diabetic rats EN Okatan, E Tuncay, G Hafez, B Turan Canadian journal of physiology and pharmacology 93 (7), 517-525, 2015 | 38 | 2015 |
| Acidosis, cognitive dysfunction and motor impairments in patients with kidney disease PH Imenez Silva, R Unwin, EJ Hoorn, A Ortiz, F Trepiccione, R Nielsen, ... Nephrology Dialysis Transplantation (Oxford University Press) 37 …, 2022 | 34 | 2022 |
| Albuminuria as a risk factor for mild cognitive impairment and dementia—what is the evidence? B Bikbov, MJ Soler, V Pešić, G Capasso, R Unwin, M Endres, G Remuzzi, ... Nephrology Dialysis Transplantation (Oxford University Press) 37 …, 2022 | 30* | 2022 |
| A new relaxant on human corpus cavernosum: Ferulago syriaca root extract B Ozturk, S Gur, M Coskun, M Kosan, CS Erdurak, G Hafez, U Gonulalan, ... Afr J Pharm Pharmacol 6 (37), 2652-2656, 2012 | 26 | 2012 |
| Cognitive disorders in patients with chronic kidney disease: Approaches to prevention and treatment M Pépin, A Klimkowicz‐Mrowiec, O Godefroy, P Delgado, S Carriazo, ... European Journal of Neurology 30 (9), 2899-2911, 2023 | 25 | 2023 |
| 237 Relaxant effect of ferulago syriaca root extract on human corpus cavernosum B Oztürk, S Gür, M Coskun, M Kosan, C Erdurak, G Hafez, O Ozgunes, ... European Urology Supplements 2 (3), 62, 2004 | 23* | 2004 |
| Alteration in contractile responses in human detrusor smooth muscle from obstructed bladders with overactivity M Kosan, M Tul, B Ozturk, G Hafez, G Inal, M Cetinkaya Urologia Internationalis 80 (2), 193-200, 2008 | 21 | 2008 |
| Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients G Hafez, J Malyszko, A Golenia, A Klimkowicz-Mrowiec, AC Ferreira, ... Clinical Kidney Journal (Oxford Academic) 16 (12), 2378-2392, 2023 | 20 | 2023 |
| Acetylsalicylic acid protects erectile function in diabetic rats G Hafez, U Gonulalan, M Kosan, E Arioglu, B Ozturk, M Cetinkaya, S Gur Andrologia 46 (9), 997-1003, 2013 | 20 | 2013 |
| Effect of urothelium on bladder contractility in diabetic rats M Koşan, G Hafez, B ÖZTüRK, O ÖZGüNES, S GüR, M Cetinkaya International journal of urology 12 (7), 677-682, 2005 | 20 | 2005 |
| Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges C Zoccali, A Ortiz, IA Blumbyte, S Rudolf, AG Beck-Sickinger, J Malyszko, ... Nephrology Dialysis Transplantation 37 (Supplement_2), ii14-ii23, 2022 | 17* | 2022 |
| Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factor S Liabeuf, V Pešić, G Spasovski, R Maciulaitis, M Bobot, A Farinha, ... Clinical Kidney Journal (Oxford Academic) 16 (12), 2365-2377, 2023 | 12 | 2023 |
| Developing a medication adherence technologies repository: proposed structure and protocol for an online real-time Delphi study UN Makovec, C Goetzinger, J Ribaut, P Barnestein-Fonseca, ... BMJ open 12 (4), e059674, 2022 | 12 | 2022 |
| The effect of diabetes mellitus on α1-adrenergic receptor subtypes in the bladder of rats U Gonulalan, M Kosan, G Hafez, E Arıoglu, O Akdemir, B Ozturk, S Gur, ... Urology 80 (4), 951. e9-951. e16, 2012 | 11 | 2012 |
| Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review M Barbieri, P Chiodini, P Di Gennaro, G Hafez, S Liabeuf, J Malyszko, ... Pharmacological Research, 107146, 2024 | 10 | 2024 |
| Brain dysfunction in tubular and tubulointerstitial kidney diseases D Viggiano, A Bruchfeld, S Carriazo, A De Donato, N Endlich, AC Ferreira, ... Nephrology Dialysis Transplantation 37 (Supplement_2), ii46-ii55, 2022 | 6 | 2022 |
| Methodological challenges and biases in the field of cognitive function among patients with chronic kidney disease K Giannakou, A Golenia, S Liabeuf, J Malyszko, F Mattace-Raso, ... Frontiers in Medicine 10, 1215583, 2023 | 5 | 2023 |
| Pan‐European survey on medication adherence management by healthcare professionals M Kamusheva, E Aarnio, M Qvarnström, G Hafez, S Mucherino, ... British Journal of Clinical Pharmacology, 2024 | 4 | 2024 |
LIABEUF SophieAMIENSPotvrđena adresa e-pošte na chu-amiens.fr
